Funds holding Genome&Company, Inc.
ISIN KR7314130006 · South Korea
- Fund holders
- 5
- Of which ETFs
- 3 2 other funds
- Value held
- 152.6K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 22,711 | 52.2K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 18,851 | 43.4K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 11,540 | 26.5K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 9,104 | 20.8K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 4,201 | 9.6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 5 | +3 | 66,407 | +44.1 % |
| 2026Q2 | 2 | 0 | 46,099 | +34.0 % |
| 2026Q1 | 2 | +1 | 34,391 | +92.1 % |
| 2025Q3 | 1 | 0 | 17,904 | 0.0 % |
| 2025Q2 | 1 | -1 | 17,904 | -20.9 % |
| 2025Q1 | 2 | -5 | 22,641 | -66.3 % |
| 2024Q4 | 7 | +2 | 67,087 | +101.6 % |
| 2024Q3 | 5 | -1 | 33,284 | -22.3 % |
| 2024Q2 | 6 | 0 | 42,827 | +18.4 % |
| 2024Q1 | 6 | +1 | 36,175 | +33.7 % |
| 2023Q4 | 5 | 27,053 |
Cite this page
Titelia. "Funds holding Genome&Company, Inc.". https://titelia.com/en/stocks/genome-company-inc-KR7314130006